What organ is affected by high triglycerides?

High triglycerides primarily affect the liver, heart, and pancreas, causing fatty liver disease, cardiovascular problems, and potentially life-threatening pancreatitis. Multiple organs work together to regulate triglycerides, making comprehensive monitoring essential for health.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

When your doctor mentions high triglycerides, you might wonder which parts of your body are actually being affected. The truth is, elevated triglycerides don't just impact one organ—they can cause problems throughout multiple body systems. Understanding which organs bear the brunt of high triglyceride levels can help you appreciate why managing these blood fats is so crucial for your overall health.

Triglycerides are a type of fat (lipid) found in your blood. When you eat, your body converts calories it doesn't need right away into triglycerides, which are stored in fat cells and released between meals for energy. While some triglycerides are necessary for normal body function, levels that are too high can spell trouble for several vital organs.

The Liver: Your Body's Fat Processing Center

The liver is perhaps the organ most directly affected by high triglycerides. As your body's primary metabolic hub, the liver plays a central role in processing fats, including triglycerides. When triglyceride levels remain elevated, excess fat can accumulate in liver cells, leading to a condition called non-alcoholic fatty liver disease (NAFLD).

Triglyceride Levels and Associated Health Risks

Triglyceride LevelClassificationOrgan ImpactHealth Risks
Less than 150 mg/dL<150 mg/dLNormalMinimal impactLow risk
150-199 mg/dL150-199 mg/dLBorderline highMild liver fat accumulationIncreased cardiovascular risk
200-499 mg/dL200-499 mg/dLHighFatty liver, arterial damageSignificant heart disease risk
500+ mg/dL≥500 mg/dLVery highRisk of pancreatitis, severe organ stressMedical emergency risk

Triglyceride levels should be measured after 9-12 hours of fasting for accurate results.

NAFLD affects approximately 25% of adults globally and is closely linked to high triglycerides. In this condition, fat makes up more than 5-10% of the liver's weight. While early stages may cause no symptoms, NAFLD can progress to more serious conditions:

  • Non-alcoholic steatohepatitis (NASH): Inflammation and liver cell damage
  • Fibrosis: Scarring of liver tissue
  • Cirrhosis: Severe scarring that can lead to liver failure
  • Increased risk of liver cancer

The liver also produces very low-density lipoproteins (VLDL), which carry triglycerides through the bloodstream. When the liver is overwhelmed with excess triglycerides, it produces more VLDL particles, creating a vicious cycle that further elevates blood triglyceride levels.

The Heart and Blood Vessels: Under Constant Pressure

Your cardiovascular system faces significant challenges when triglyceride levels climb too high. Elevated triglycerides contribute to atherosclerosis—the hardening and narrowing of arteries due to plaque buildup. This process doesn't happen overnight but develops gradually as triglyceride-rich particles deposit along artery walls.

High triglycerides affect your heart and blood vessels in several ways:

  • Increased risk of coronary artery disease
  • Higher likelihood of heart attacks and strokes
  • Elevated blood pressure
  • Reduced HDL (good) cholesterol levels
  • Formation of small, dense LDL particles that are particularly harmful to arteries

Research shows that people with triglycerides above 150 mg/dL have a significantly increased risk of cardiovascular events. When levels exceed 500 mg/dL, the risk becomes even more pronounced. Regular monitoring of your triglycerides alongside other cardiovascular markers can help you stay ahead of potential heart problems.

The Pancreas: A Critical but Often Overlooked Target

While the liver and heart often get the most attention, the pancreas can suffer severe consequences from extremely high triglycerides. When triglyceride levels exceed 500 mg/dL, and especially when they surpass 1,000 mg/dL, the risk of acute pancreatitis increases dramatically.

Hypertriglyceridemia-induced pancreatitis occurs when excess triglycerides in the blood trigger inflammation in the pancreas. This condition is a medical emergency that can cause:

  • Severe abdominal pain
  • Nausea and vomiting
  • Fever
  • Rapid pulse
  • Potential organ failure in severe cases

The pancreas also plays a crucial role in blood sugar regulation by producing insulin. High triglycerides are often associated with insulin resistance, creating a bidirectional relationship where each condition can worsen the other. This connection explains why people with diabetes often struggle with elevated triglycerides.

Understanding Triglyceride Levels and Their Impact

To understand how triglycerides affect your organs, it's important to know what constitutes normal versus elevated levels. The following ranges help determine your risk level.

These levels directly correlate with the degree of organ impact. While mild elevations might cause subtle changes in liver function, very high levels can trigger acute organ damage, particularly in the pancreas.

Other Organs Affected by High Triglycerides

The Kidneys

Your kidneys can also suffer from chronically elevated triglycerides. High levels contribute to chronic kidney disease through several mechanisms, including increased inflammation, oxidative stress, and damage to the small blood vessels that filter waste from your blood. People with both high triglycerides and kidney disease face a compounded risk of cardiovascular complications.

The Brain

Emerging research suggests that high triglycerides may affect brain health and cognitive function. Elevated levels have been associated with an increased risk of stroke, vascular dementia, and potentially Alzheimer's disease. The mechanism likely involves damage to small blood vessels in the brain and increased inflammation.

Fat Tissue

While not an organ in the traditional sense, adipose (fat) tissue plays an active role in triglyceride metabolism. Dysfunctional fat tissue can release excess free fatty acids into the bloodstream, which the liver then converts into triglycerides. This creates a cycle where obesity contributes to high triglycerides, which in turn promotes further fat storage.

Symptoms That Your Organs Are Being Affected

High triglycerides often cause no symptoms until organ damage has already begun. However, some warning signs may indicate that your organs are under stress:

  • Fatigue and weakness (liver involvement)
  • Abdominal pain or discomfort (liver or pancreas)
  • Xanthomas (fatty deposits under the skin)
  • Chest pain or shortness of breath (cardiovascular impact)
  • Confusion or memory problems (potential brain involvement)
  • Swelling in legs or ankles (heart or kidney issues)

If you experience any of these symptoms, especially in combination with known risk factors for high triglycerides, it's important to get your levels checked promptly.

Risk Factors for Organ Damage from High Triglycerides

Several factors increase your likelihood of developing organ complications from elevated triglycerides:

  • Obesity, particularly abdominal obesity
  • Type 2 diabetes or prediabetes
  • Excessive alcohol consumption
  • Diet high in refined carbohydrates and sugars
  • Sedentary lifestyle
  • Certain medications (steroids, beta-blockers, some diuretics)
  • Genetic disorders affecting lipid metabolism
  • Hypothyroidism
  • Chronic kidney disease

Understanding your personal risk factors can help you and your healthcare provider develop an appropriate monitoring and treatment strategy to protect your organs from damage.

Protecting Your Organs: Prevention and Management Strategies

The good news is that high triglycerides are often manageable through lifestyle changes and, when necessary, medication. Here are evidence-based strategies to protect your organs:

Dietary Modifications

  • Reduce simple carbohydrates and added sugars
  • Increase omega-3 fatty acids from fish or supplements
  • Choose whole grains over refined grains
  • Limit alcohol consumption
  • Increase fiber intake from vegetables, fruits, and legumes
  • Control portion sizes to maintain healthy weight

Lifestyle Changes

  • Engage in regular physical activity (at least 150 minutes per week)
  • Achieve and maintain a healthy weight
  • Quit smoking
  • Manage stress through meditation, yoga, or other techniques
  • Get adequate sleep (7-9 hours per night)
  • Stay hydrated

Medical Management

When lifestyle changes aren't enough, medications may be necessary to protect your organs from damage. Common options include fibrates, omega-3 fatty acid supplements, niacin, and statins. Your healthcare provider can determine the best approach based on your triglyceride levels and overall health profile.

The Importance of Regular Monitoring

Given that high triglycerides often cause no symptoms until significant organ damage has occurred, regular monitoring is crucial. The American Heart Association recommends that adults have their triglycerides checked at least every 4-6 years, or more frequently if you have risk factors or elevated levels.

Comprehensive lipid panels that include triglycerides, along with other important markers like HDL, LDL, and total cholesterol, provide a complete picture of your cardiovascular health. Advanced testing can also include markers like ApoB and ApoA1, which offer additional insights into your risk profile. Regular monitoring allows you to track your progress and adjust your management strategy as needed.

Taking Action to Protect Your Organs

High triglycerides affect multiple organs throughout your body, with the liver, heart, and pancreas bearing the greatest burden. The interconnected nature of these effects means that addressing elevated triglycerides can have wide-ranging benefits for your overall health. By understanding which organs are at risk and taking proactive steps to manage your levels, you can significantly reduce your risk of serious complications.

Remember that triglyceride management is not just about avoiding acute problems like pancreatitis—it's about protecting your long-term health and maintaining optimal function of vital organs. Whether through lifestyle modifications, medication, or a combination of both, taking control of your triglyceride levels is an investment in your future health and well-being.

References

  1. Berglund L, Brunzell JD, Goldberg AC, et al. Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2012;97(9):2969-2989.[Link][PubMed][DOI]
  2. Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73-84.[Link][PubMed][DOI]
  3. Nordestgaard BG. Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology. Circ Res. 2016;118(4):547-563.[Link][PubMed][DOI]
  4. Scherer J, Singh VP, Pitchumoni CS, Yadav D. Issues in hypertriglyceridemic pancreatitis: an update. J Clin Gastroenterol. 2014;48(3):195-203.[Link][PubMed][DOI]
  5. Miller M, Stone NJ, Ballantyne C, et al. Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2011;123(20):2292-2333.[Link][PubMed][DOI]
  6. Vaziri ND. Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences. Am J Physiol Renal Physiol. 2006;290(2):F262-F272.[Link][PubMed][DOI]

Frequently Asked Questions

How can I test my triglycerides at home?

You can test your triglycerides at home with SiPhox Health's Heart & Metabolic Program, which includes triglycerides testing along with other essential cardiovascular markers. The program provides CLIA-certified lab results from a simple at-home blood draw.

What is the most dangerous organ complication from high triglycerides?

Acute pancreatitis is the most immediately dangerous complication, occurring when triglycerides exceed 500-1,000 mg/dL. This medical emergency can cause severe pain, organ failure, and even death. However, long-term cardiovascular damage from moderately elevated triglycerides causes more deaths overall.

Can high triglycerides be reversed?

Yes, high triglycerides can often be reversed through lifestyle changes including dietary modifications, weight loss, regular exercise, and limiting alcohol. Many people see significant improvements within 2-3 months of making these changes. Medication may be needed for very high levels or genetic conditions.

What foods should I avoid if I have high triglycerides?

Avoid foods high in simple sugars (sodas, candy, baked goods), refined carbohydrates (white bread, pasta), alcohol, and foods with trans fats. Also limit saturated fats from red meat and full-fat dairy products. Focus instead on whole grains, lean proteins, and foods rich in omega-3 fatty acids.

How quickly can triglyceride levels change?

Triglyceride levels can change rapidly - even within hours after eating a fatty meal. For meaningful changes from lifestyle modifications, most people see improvements within 2-4 weeks, with more significant changes occurring over 2-3 months of consistent healthy habits.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details